Hiroyasu Koike Purchases NMR Shares
NMR's Head of Investment Management, Hiroyasu Koike, bought 274 shares recently.
Key Points
- Hiroyasu Koike, Head of Investment Management at NMR, purchased 274 shares at $8.86 each on June 25, 2026.
- Shares of NMR traded near $8.79 on Monday, reflecting a stable market presence.
- Several institutional investors like Morgan Stanley and BlackRock increased their stakes in NMR recently.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 25, 2026, Hiroyasu Koike, the Head of Investment Management at NMR, purchased 274 shares of the company at an average price of $8.86 each. This transaction was not part of a pre-arranged trading plan, and the total value of the purchase was $2,427.64.
Insider Buying and Selling at Nomura Holdings, Inc.
Several insiders at NMR made purchases on June 25, 2026. Masahiro Ishizuka bought 205 shares, while Akihito Tobari, the Head of Wealth Management, and Akio Hori, the Chief Information Officer, each acquired 71 shares. Shoji Ogawa added 204 shares, and Yukiko Ozaki, who holds dual roles as CHRO and CHO, purchased 8 shares. All transactions were executed at $8.86 per share and were not planned in advance.
Other Institutional Activity in NMR
Institutional investors have been active in NMR recently. Donald Smith & Co. increased its holdings by 473,959 shares, bringing its total to 13,169,493 shares valued at approximately $103.9 million. Morgan Stanley added 762,095 shares, resulting in a 7.8% increase to 10,577,455 shares worth about $83.5 million. BlackRock also grew its stake by 635,935 shares, a 13.3% increase, ending with 5,421,666 shares valued at $42.8 million. Meanwhile, Fisher Asset Management slightly reduced its position by 59,894 shares to 13,091,620 shares, valued at $103.3 million.
Nomura Holdings, Inc. Stock Down 14.7%
Shares of NMR traded near $8.79 on Monday. The stock has been relatively stable, with a 52-week range that hasn't been provided here. NMR's current trading activity reflects a steady presence in the market, supported by the recent insider and institutional activities.
$NMR stock price
Daily closing prices, year to date. Not investment advice.
Bottom Line
Insider buying at NMR, including Hiroyasu Koike's recent purchase, indicates confidence from the company's leadership. Institutional investors have also shown interest, with several funds increasing their stakes. While these transactions provide insight into ownership trends, it's important to remember that they reflect past actions and may not indicate current or future positions.
Get Nomura Holdings, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NMR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.